Leading small business
innovation and commercialization
in the fight against cancer
The SBIR & STTR Programs are one of the largest sources of early stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities.
Learn how NCI SBIR & STTR Programs have helped small businesses with funding awards that help advance cancer research.
Their MxStructure™ software uses auto-segmentation to better focus radiation treatment and minimize exposure to surrounding healthy tissue. They were acquired by Accuray in 2012.
AntiCancer, the San Diego-based biotechnology company, was awarded Phase I and II SBIR grants and contracts that have led to the commercialization of three cancer research tools: MetaMouse®, AngioMouse®, and OncoBrite®.
Awarded more than $4 million to develop a technology platform of safe and effective carriers for therapeutic vaccines based on hemocyanin from the keyhole limpet (KLH) protein.
We will be at the 18th Annual HHS SBIR/STTR Conference from November 15 to 17!
The 2016 Omnibus Grant FOAs for SBIR and STTR are now available!
The applications for the FY2017 Phase IIB Bridge Award are due on July 13, 2016.
Both SBIR and STTR Phase II awardees from other Federal agencies are now welcome to apply. Check the Funding Opportunity Announcement for detailed eligibility criteria.